NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/11/2026 10:32
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9,681.85 mln
Float75.95 mln
Earnings Date07/29/2026
EPS
7.42
Strong
P / E
16.42
Moderately valued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.54
Likely reliable
1-Year Forecast
137
Modest upside
Relative Strength
92
/ 100
Top performer
Business Description
Founded in 1989 and headquartered in Dublin, Ireland, ICON Public Limited Company helps pharmaceutical, biotechnology, medical device, and public health organizations bring new treatments to market. The company manages the full journey of clinical trials, from early compound testing through all phases of development and beyond, offering services that include laboratory work, data analysis, patient access, medical imaging, and regulatory support. ICON also provides consulting, contract staffing, and commercial strategy services to help clients design, run, and complete studies efficiently. The company operates across Europe, the United States, and internationally, and maintains a strategic partnership with Advarra Inc. to build a connected network of trial-ready research sites.